Cargando…

Efficacy and safety of once-monthly Risperidone ISM(®) in schizophrenic patients with an acute exacerbation

To evaluate the efficacy and safety of Risperidone ISM(®) against placebo in patients with acute exacerbation of schizophrenia. A multicenter, randomized, double-blind, placebo-controlled study was conducted between June 2017 and December 2018 (NCT03160521). Eligible patients received once-monthly i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correll, Christoph U., Litman, Robert E., Filts, Yuriy, Llaudó, Jordi, Naber, Dieter, Torres, Ferran, Martínez, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688968/ https://www.ncbi.nlm.nih.gov/pubmed/33239746 http://dx.doi.org/10.1038/s41537-020-00127-y

Ejemplares similares

Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM
por: Litman, Robert, et al.
Publicado: (2023)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
por: Walling, David P, et al.
Publicado: (2021)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]
Publicado: (2022)

Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations
por: Tchobaniouk, Lesia V, et al.
Publicado: (2019)

Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review
por: Álamo, Cecilio
Publicado: (2022)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2007)

Early onset of treatment effects with oral risperidone
por: Raedler, Thomas J, et al.
Publicado: (2007)

Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM(®): results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studies
por: Sánchez, Pedro, et al.
Publicado: (2023)

Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly
por: Correll, Christoph U., et al.
Publicado: (2023)

Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population
por: Almoguera, B, et al.
Publicado: (2013)

Risperidone-Induced Neutropenia in a Schizophrenic Patient: A Case Report and Literature Review
por: Atolagbe, Ayodele, et al.
Publicado: (2021)

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
por: Schöttle, Daniel, et al.
Publicado: (2018)

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
por: Schöttle, Daniel, et al.
Publicado: (2018)

Effects of risperidone and olanzapine on remnant-like lipoprotein particle cholesterol (RLP-C) in schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2008)

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
por: Patel, Charmi, et al.
Publicado: (2019)

Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report
por: Theleritis, Christos G, et al.
Publicado: (2006)

The Tolerability of Mirtazapine Augmentation in Schizophrenic Patients Treated with Risperidone: A Preliminary Randomized Placebo-controlled Trial
por: Lee, Jieun, et al.
Publicado: (2011)

The Comparison of Olanzapine and Risperidone Treatment in Male Schizophrenic Patients using Positive and Negative Syndromes Scale (PANSS)
por: Lestari, Endah Tri, et al.
Publicado: (2018)

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
por: Sahlsten Schölin, Johan, et al.
Publicado: (2023)

Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study
por: Dhanda, Rahul, et al.
Publicado: (2019)

Workshop on Observations to Self-Consistent Modelling of the ISM in Galaxies
por: Avillez, Miguel, et al.
Publicado: (2004)

Black Looks ... at 'Isms'
por: Black, Douglas
Publicado: (1992)

Buffalo as an ISM Center
Publicado: (1900)

simpleISM—A straight forward guide to upgrade from confocal to ISM
por: Goswami, Monalisa, et al.
Publicado: (2022)

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder
por: Fu, Dong-Jing, et al.
Publicado: (2016)

Unmasking of Myasthenia Gravis After Introduction of Oral Risperidone in a Schizophrenic Saudi Male: A Case Report
por: Abualkhair, Lamees, et al.
Publicado: (2021)

Modern Isms and Ologies, (Poetical)
Publicado: (1874)

The Cure of Cancer by Mattei-ism
por: Boncher, M. Louis
Publicado: (1892)

A Third “Ism”: Ageism
por: DeMaria, Anthony
Publicado: (2023)

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval
por: Gharabawi, Georges M, et al.
Publicado: (2007)

Negative Correlation between Serum S100B and Leptin Levels in Schizophrenic Patients During Treatment with Clozapine and Risperidone: Preliminary Evidence
por: Hendouei, Narjes, et al.
Publicado: (2016)

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY
por: Potkin, Steven G., et al.
Publicado: (2017)

ACUTE SCHIZOPHRENIC EPISODES—ARE THEY SCHIZOPHRENIC?
por: Singh, Gurmeet, et al.
Publicado: (1981)

Workshop in the Neutral ISM in Starburst Galaxies
Publicado: (2003)

Lobelia—Ism—Its Prospects and Policy
por: Smith, J. Dickson
Publicado: (1860)

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France
por: Limosin, Frédéric, et al.
Publicado: (2018)

Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate
por: Mathews, Maju, et al.
Publicado: (2018)

Today's isms; comunism, fascism, capitalism, socialism
por: Ebenstein, William, 1910-1976
Publicado: (1970)

Expressionnisme, dada, surréalisme et autres ismes /
por: Fauchereau, Serge
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_jh9aldi862geg4e1qd0oqfaqmj